Karen Daily, D.O.

Karen Daily, D.O.

(352) 265-0725

Current patients:
Log in to MyUFHealth

Publications

The association between cognitive impairment and breast and colorectal cancer screening utilization.
BMC cancer
2021

Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma.
The oncologist
2021

Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
Annals of surgical oncology
2021

Epidemiology of De Novo Metastatic Breast Cancer.
Clinical breast cancer
2021

Does definitive local therapy have a role in select HER2+ de novo metastatic breast cancer patients treated with dual anti-HER2 blockade?
Breast cancer research and treatment
2021

Chemotherapy education: current practices of oncology nurses counseling patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
2021

Activity of Sorafenib Plus Capecitabine in Previously Treated Metastatic Colorectal Cancer.
The oncologist
2021

Acinic Cell Carcinoma of the Breast: Report of a Case With Immunohistochemical and Next-Generation Sequencing Studies.
International journal of surgical pathology
2021

ASO Visual Abstract: A 5-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
Annals of surgical oncology
2021

Outcomes of primary endocrine therapy in elderly women with stage I-III breast cancer: a SEER database analysis.
Breast cancer research and treatment
2020

How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial.
Clinical pharmacology and therapeutics
2020

Concomitant Radiation Recall Dermatitis and Organizing Pneumonia following Breast Radiotherapy: A Case Report.
Case reports in oncology
2020

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
JAMA oncology
2020

A case for Tamoxifen with ovarian function suppression.
Breast cancer research and treatment
2020

Projected clinical benefit of surveillance imaging for early detection and treatment of breast cancer metastases.
The breast journal
2019

Women's Health Curriculum for Medical Students.
Southern medical journal
2018

Tumour lysis syndrome following eribulin for metastatic uterine leiomyosarcoma.
BMJ case reports
2018

The Toxicity of Time.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2018

Epidemiological, Clinical, and Histopathological Features of Breast Cancer in Haiti.
Journal of global oncology
2018

Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review.
Clinical Medicine Insights. Oncology
2018

Stereotactic body radiation therapy for oligoprogression of metastatic disease from gastrointestinal cancers: A novel approach to extend chemotherapy efficacy.
Oncology letters
2017

Gemcitabine-induced chronic systemic capillary leak syndrome.
BMJ case reports
2017

Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma.
Journal of gastrointestinal oncology
2016

Development of a Breast Cancer Treatment Program in Port-au-Prince, Haiti: Experiences From the Field.
Journal of global oncology
2016

Hepatoid adenocarcinoma of the colon.
BMJ case reports
2015

Hepatoid Adenocarcinoma of the Colon

2015

Breast Cancer: Instructional Module

2015

Preventing breast cancer recurrence through a tailored lifestyle intervention: The MyLIFE (My Lifestyle Intervention with Food and Exercise) Trial Rationale and Study Design

2014

Controversies in Adjuvant Chemotherapy

2014

Common variable immunodeficiency syndrome in an adult.
Lancet (London, England)
2014

Peers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2013

Research Interests

Through her role as the Breast Cancer Disease Site Group’s Research Leader, Dr. Daily is dedicated to increasing available clinical trials, both large cooperative group studies and early phase single institution investigations, so that every patient may be offered the opportunity to participate. She is an active member of the National Surgical Adjuvant Bowel and Breast Project (NSABP) and serves as Co-Chair of the Rare Breast Cancer Committee.

Active Research Studies